Sartans improve survival, time to recurrence in liver cancer
(HealthDay)—For patients with hepatocellular carcinoma after radiofrequency ablation, angiotensin II receptor 1 blockers (sartans) correlate with significantly improved overall survival and time to recurrence, according ...
Oct 26, 2015
0
12